‘Never-before-seen breakthroughs in diagnostic research and technology’ were revealed during July’s American Association for Clinical Chemistry meeting in Chicago, where up to 20,000 people packed in for research updates.
In uncomplicated stable angina cases no evidence suggests that angioplasty reduces heart attacks or death risks, Mark Nicholls reports
Vygon, the specialist single-use medical devices group, today announces its acquisition of Medwin, a company based in southern France, specialized in enteral nutrition (feeding pumps) and related accessories.
By recognition and early intervention against the most significant risk factors, many heart diseases can be prevented.
Clinicians and companies remain committed to a procedure that failed to demonstrate efficacy against a sham-control group in pivotal clinical trial
A cardiac surgeon, Wolfgang Goetz MD once stitched together custom aortic valves in the operating room. Today he is CEO of Transcatheter Technologies in Regensburg.
Sepsis kills around a hundred and thirty patients daily In Germany alone. This systemic disease is mostly caused by bacterial pathogens, and less frequently by fungal organisms or parasites. The delayed diagnoses result in high mortality. Professor Dr Frank M Brunkhorst of the Centre of Sepsis Control and Care (CSCC), at Jena University Hospital, Germany, is seeking strategies to combat such…
Acquisition to further industry innovation with a combined $650 million annual R&D investment Complementary client bases expand global presence.
Whilst participants at the ‘Boundary-less Hospital in Health Care Networks’ conference, organised by the Centre for Advanced Studies in Management (CASiM) at Leipzig Graduate School of Management (HHL) in mid-June agreed on the need as such, there was plenty of room to discuss exactly which changes could make the German healthcare system future-ready.
Beckman Coulter, an indirect wholly-owned subsidiary of Danaher Corporation (NYSE:DHR), announced today that it has entered into a definitive agreement to purchase the clinical microbiology business of Siemens Healthcare Diagnostics.
On the leading edge of automation for medical laboratory testing, Siemens Healthcare rolled out an impressive suite of new products at IFCC WorldLab 2014 in Istanbul, Turkey that are ‘exactly aligned, and even anticipate, customer needs in central lab operations,’ according to Franz Walt, CEO for the Chemistry, Immunoassay, Automation and Diagnostics IT business unit within Siemens’…
As many laboratories face demands to turn around faster, more accurate patient test results against a backdrop of increasingly stringent quality control and tighter budgets, the search is on for tools to help meet ever-stretching targets.
Free fertility treatment should be banned for those making "lifestyle" reproductive choices, such as sterilisation reversal or single motherhood for fertile women. And fertility clinics should be subject to carbon capping schemes, in a bid to help curb climate change, argues a bioethicist in the Journal of Medical Ethics.
Researchers from the University of Heidelberg and the German Cancer Research Center (DKFZ) have developed a new method that uses light to control processes in living cells.
Smoking prevalence is 50% higher in this group; Researchers say that more effort is needed to help them quit.
Researchers at Johns Hopkins Bayview Medical Center used two relatively simple tactics to significantly reduce the number of unnecessary blood tests to assess symptoms of heart attack and chest pain and to achieve a large decrease in patient charges.
John Power is breathing easier after agreeing to let the Philips Home Healthcare deal with the complex and competitive consumer market for medical technology.
At a glance, StreetLab looks like a city street, peppered with shops and street signs. However, this special area belongs to the Paris-based Vision Institute.
You never know what you’re going to see in the Emergency Department (ED); but, more and more the first evaluation of a trauma patient’s condition will be with ultrasound.
For several decades pathologists worldwide have been under increasing pressure to handle a steady increase in laboratory tests with a steady decrease in finance and staff.
Although nosocomial infections and medical accidents have declined, over 750 hospitals with the highest number of such cases now face penalties – amounting to an estimated $330 million a year – issued by Medicare.
Scientists in the UK are working to develop a hand-held testing device to provide same day diagnosis from a patient’s bedside. The device will use disposable cartridges and utilise printed circuit board technology (PCB) that will allow a fast and low-cost diagnosis.
Coping with the side effects of chemotherapy treatment is challenging for people with cancer. When fatigued or nauseous, it is not easy to assess if these conditions are acceptable treatment side effects or require medical assistance.
This April, in San Jose, California, the portable lab took central stage at the American Association for Clinical Chemistry’s (AACC) annual forum for emerging clinical diagnostic technologies – a most appropriate topic for the Silicon Valley venue where so many world-changing computer and communications innovations have been born.
Two companies with similar core values, providing high quality products for acute care and point-of-care testing worldwide.